Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microalbuminuria, endothelial dysfunction and cardiovascular risk.

B Feldt-Rasmussen1

  • 1Nephrological Department, Rigshospitalet, Copenhagen, Danemark. BFR@RH.DK

Diabetes & Metabolism
|August 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased vulnerability to COVID-19 in chronic kidney disease.

Journal of internal medicine·2021
Same author

Prevalence of impaired renal function in virologically suppressed people living with HIV compared with controls: the Copenhagen Comorbidity in HIV Infection (COCOMO) study.

HIV medicine·2019
Same author

Response to the comments on 'Continuation of lithium after a diagnosis of chronic kidney disease'.

Acta psychiatrica Scandinavica·2018
Same author

Continuation of lithium after a diagnosis of chronic kidney disease.

Acta psychiatrica Scandinavica·2017
Same author

Error in Author Affiliations. Use of lithium and anticonvulsants and the rate of chronic kidney disease: a nationwide population-based study.

JAMA psychiatry·2016
Same author

Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients.

Diabetologia·2011
Same journal

Glucagon-like peptide-1 receptor agonists and risk of pancreaticobiliary cancers in patients with type 2 diabetes: a nationwide cohort study.

Diabetes & metabolism·2026
Same journal

Decreased risk of new-onset osteoporosis in patients with Type 2 diabetes on SGLT-2 inhibitors.

Diabetes & metabolism·2026
Same journal

Two faces of autoimmune hyperinsulinemia: contrasting type B insulin resistance syndrome and exogenous insulin antibody syndrome.

Diabetes & metabolism·2026
Same journal

CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study.

Diabetes & metabolism·2026
Same journal

Persistent burden and management gaps of hypoglycemia in pediatric type 1 diabetes: insights from the Epi-GLUREDIA Study.

Diabetes & metabolism·2026
Same journal

Blood oxygen saturation and its associations with autonomic and peripheral neuropathy in diabetes.

Diabetes & metabolism·2026
See all related articles

Microalbuminuria, or increased albumin in urine, is a significant risk factor for cardiovascular disease in diabetic and non-diabetic individuals. This condition may indicate underlying endothelial dysfunction, a potential link to cardiovascular events.

Area of Science:

  • Cardiovascular Research
  • Nephrology
  • Endocrinology

Background:

  • Microalbuminuria was initially recognized as a key risk factor for diabetic nephropathy.
  • Emerging evidence highlights microalbuminuria as an independent predictor of cardiovascular morbidity and mortality in both Type 1 and Type 2 diabetes.
  • Importantly, microalbuminuria also signifies increased cardiovascular mortality risk in the general population without diabetes.

Purpose of the Study:

  • To investigate the link between elevated urinary albumin excretion and cardiovascular disease and mortality.
  • To explore the potential role of endothelial dysfunction as a common pathway connecting microalbuminuria and cardiovascular outcomes.

Main Methods:

  • Reviewing studies examining the association between microalbuminuria and cardiovascular events.

Related Experiment Videos

  • Analyzing data on transcapillary escape rate of albumin (TER-alb) in individuals with microalbuminuria.
  • Evaluating markers and functional tests of endothelial dysfunction in diabetic and non-diabetic populations with microalbuminuria.

    • Main Results:

    • Microalbuminuria is associated with an increased transcapillary escape rate of albumin (TER-alb), suggesting a universal vascular sieving issue.
    • Evidence suggests endothelial dysfunction is present in patients with microalbuminuria.
    • Functional in vivo tests confirm vascular dysfunction in diabetic and non-diabetic individuals with microalbuminuria, potentially linked to endothelial cell dysfunction.

    Conclusions:

    • Microalbuminuria may serve as a marker for a broader vascular dysfunction, particularly endothelial dysfunction.
    • Endothelial dysfunction is a plausible common mechanism linking microalbuminuria to increased cardiovascular risk.
    • Further research into endothelial function is warranted for understanding and managing cardiovascular risks associated with microalbuminuria.